FRENLOSIRSEN SODIUM
UNII J2MMX1VR5I

Substance Identification & Data

This profile provides standardized clinical and technical data for Frenlosirsen Sodium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) J2MMX1VR5I.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2304711-82-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

J2MMX1VR5I

CAS Registry Number

2304711-82-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

FRENLOSIRSEN SODIUM

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C180644

National Cancer Institute reference terminology for clinical and research data.

USAN ID

HI-05

Identifier assigned by the United States Adopted Names Council.

Substance Type

nucleicAcid

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Frenlosirsen Sodium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FRENLOSIRSEN SODIUM

Common Names & Synonyms

FRENLOSIRSEN SODIUM [USAN]

Systematic Nomenclature

ALL-P-AMBO-2'-O,4'-C-((S)-ETHYLIDENE)-P-THIOADENYLYL-(3'-O->5-O)-2'-O,4'-C-((S)-ETHYLIDENE)-P-THIOGUANYLYL-(3'-O->5'-O)-P-THIOTHYMIDYLYL-(3'-O->5'-O)-P-THIOTHYMIDYLYL-(3'-O->5'-O)-2'-DEOXY-P-THIOGUANYLYL-(3'-O->5'-O)-P-THIOTHYMIDYLYL-(3'-O->5'-O)-2'-DEOXY-P-THIOADENYLYL-(3'-O->5'-O)-2'-DEOXY-P-THIOADENYLYL-(3'-O->5'-O)-2'-DEOXY-P-THIOADENYLYL-(3'-O->5'-O)-P-THIOTHYMIDYLYL-(3'-O->5'-O)-2'-DEOXY-P-THIOGUANYLYL-(3'-O->5'-O)-2'-O-(2-METHOXYETHYL)-P-THIOADENYLYL-(3'-O->5'-O)-2'-O-(2-METHOXYETHYL)-P-THIOGUANYLYL-(3'-O->5'-O)-2'-O-(2-METHOXYETHYL)-5-METHYL-P-THIOURIDYLYL-(3'-O->5'-O)-2'-O,4'-C-((S)-ETHYLIDENE)-5-METHYL-P-THIOCYTIDYLYL-(3'-O->5'-O)-2'-O,4'-C-((S)-ETHYLIDENE)GUANOSINE, PENTADECASODIUM SALT

SYS

DNA, D(P-THIO)((2',5'-ANHYDRO-6'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-MANNOFURANO)A-(3'->4')-(2',5'-ANHYDRO-6'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-MANNOFURANO)G-T-T-G-T-A-A-A-T-G-(2'-O-(2-METHOXYETHYL))RA-(2'-O-(2-METHOXYETHYL))RG-(2'-O-(2-METHOXYETHYL))M5RU-(3'->4')-(2',5'-ANHYDRO-6'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-MANNOFURANO)M5C-(3'->4')-(2',5'-ANHYDRO-6'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-MANNOFURANO)G), SODIUM SALT (1:15)

SYS